Marco Londei, MD
Dr. Londei most recently was the Chief Executive Officer of Gadeta. Prior to Gadeta, he was the Chief Development Officer and Chief Medical Officer of AnaptysBio (NASDAQ: ANAB), where he played a crucial role in the company’s transition from its preclinical phase to its successful IPO, and several rounds of financing as a clinical stage […]
Luigi Naldini, MD, PhD
Dr. Luigi Naldini, is Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Scientific Director of the San Raffaele Telethon Institute for Gene Therapy (Milan, Italy). He has received his medical degree from the University of Turin (Italy) and his PhD from the […]
Vijay Kuchroo, DVM, PhD
Dr. Vijay Kuchroo is the Samuel L. Wasserstrom Professor of Neurology at Harvard Medical School, Senior Scientist at Brigham and Women’s Hospital, and Co-Director of the Center for Infection and Immunity, at the Brigham Research Institutes, Boston. He is also an associate member of the Broad Institute, and a participant in a Klarman Cell Observatory […]
Richard A. Flavell, PhD, FRS
Dr. Flavell is Sterling Professor of Immunobiology at Yale University School of Medicine, and an Investigator of the Howard Hughes Medical Institute. He received his B.Sc. (Honors) in 1967 and Ph.D. in 1970 in biochemistry from the University of Hull, England, and performed postdoctoral work in Amsterdam (1970-72) with Piet Borst and in Zurich (1972-73) […]